A comparison of epinephrine only, arginine vasopressin only, and epinephrine followed by arginine vasopressin on the survival rate in a rat model of anaphylactic shock

Anesthesiology

Volumn 106, Issue 5, 2007, Pages 977-983

  Dewachter, Pascale ^a,b   Raëth Fries, Isabelle ^c   Jouan Hureaux, Valérie ^c   Menu, Patrick ^d   Vigneron, Claude ^c   Longrois, Dan ^a,b   Mertes, Paul Michel ^a,b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE LORRAINE   (France)

^d NANCY UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ARGIPRESSIN; OVALBUMIN;

ANAPHYLACTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BROWN NORWAY RAT; COMBINATION CHEMOTHERAPY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE TITRATION; EXPERIMENTAL MODEL; FIRST AID; INTUBATION; MEAN ARTERIAL PRESSURE; MONOTHERAPY; MUSCLE LEVEL; NONHUMAN; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; RANDOMIZATION; RAT; RESUSCITATION; SKELETAL MUSCLE; SURVIVAL RATE; TREATMENT OUTCOME;

ANAPHYLAXIS; ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; EPINEPHRINE; INFUSIONS, INTRAVENOUS; RATS; RATS, INBRED BN; SURVIVAL RATE; WEIGHT LOSS;

EID: 34247566094     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/01.anes.0000265157.09438.1f     Document Type: Article

References (42)

1. Mitsuhata H, Matsumoto S, Hasegawa J: The epidemiology and clinical features of anaphylactic and anaphylactoid reactions in the perioperative period in Japan. Masui 1992; 41:1664-9
2. Currie M, Webb R, Williamson J, Russell W, Mackay P: The Australian Incident Monitoring Study. Clinical anaphylaxis: An analysis of 2000 incident reports. Anaesth Intensive Care 1993; 21:621-5
3. Lienhart A, Auroy Y, Pequignot F, Benhamou D, Warszawski J, Bovet M, Jougla E: Survey of anesthesia-related mortality in France. ANESTHESIOLOGY 2006; 105:1087-97
4. Longrois D: Quel est le traitement de la réaction allergique survenant en cours d'anesthésie et en particulier du choc anaphylactique? Ann Fr Anesth Reanim 2002; 21 (suppl 1):168-80
5. American Heart Association: Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: 10.6. Anaphylaxis. Circulation 2005; 112:IV143-5
6. Sneyd JR: Catecholamine-resistant cardiovascular collapse after propofol, atracurium and gentamicin. Eur J Anaesthesiol 1998; 15:600-2
7. Heytman M, Rainbird A: Use of alpha-agonists for management of anaphylaxis occurring under anaesthesia: Case studies and review. Anaesthesia 2004; 59:1210-5
8. Hepner DL: From the laboratory to the bedside: Searching for an understanding of anaphylaxis. ANESTHESIOLOGY 2005; 103:1-2
9. Kill C, Wranze E, Wulf H: Successful treatment of severe anaphylactic shock with vasopressin. Int Arch Allergy Immunol 2004; 134:260-1
10. Schummer W, Schummer C, Wippermann J, Fuchs J: Anaphylactic shock: Is vasopressin the drug of choice? ANESTHESIOLOGY 2004; 101:1025-7
11. Williams SR, Denault AY, Pellerin M, Martineau R: Vasopressin for treatment of shock following aprotinin administration. Can J Anesth 2004; 51:169-72
12. Dewachter P, Jouan-Hureaux V, Lartaud I, Bello G, de Talancé N, Longrois D, Mertes PM: Comparison of arginine vasopressin, terlipressin or epinephrine to correct hypotension in a model of anaphylactic shock in anesthetized Brown Norway rats. ANESTHESIOLOGY 2006; 104:734-41
13. 2: Indicator of peripheral tissue perfusion in haemorrhagic shock. Adv Exp Med Biol 1977; 94:585-92
14. van der Kleij A, de Koning J, Beerthuizen G, Goris R, Kreuzer F, Kimmich H: Early detection of hemorrhagic hypovolemia by muscle oxygen pressure assessment: Preliminary report. Surgery 1983; 93:518-24
15. Drucker W, Pearce F, Glass-Heidenreich L, Hopf H, Powell C, Ochsner M, Frankel H, Murray D, Nelson M, Champion H, Rozycki G, Silva J, Malcom D, DeNobile J, Harviel D, Rich N, Hunt TK: Subcutaneous tissue oxygen pressure: A reliable index of peripheral perfusion in humans after injury. J Trauma 1996; 40:S116-22
16. Ragheb J, Buggy DJ: Tissue oxygen tension in anaesthesia and perioperative medicine. Br J Anaesth 2004:464-8
17. Dewachter P, Jouan-Hureaux V, Franck P, Menu P, de Talance N, Zannad F, Laxenaire MC, Longrois D, Mertes PM: Anaphylactic shock: A form of distributive shock without inhibition of oxygen consumption. ANESTHESIOLOGY 2005; 103:40-9
18. St A Stewart L, Martin WJ: Evaluation of postoperative analgesia in a rat model of incisional pain. Contemp Top Lab Anim Sci 2003; 42:28-34
19. Practice Parameters of the Joint Task Force on Practice Parameters for Allergy and Immunology: The diagnosis and management of anaphylaxis: An updated practice parameter. J Allergy Clin Immunol 2005; 115:S483-523
20. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshazll JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM, for the Surviving Sepsis Campaign Management Guidelines Committee: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004; 32:858-73
21. Sampson H, Mendelson L, Rosen J: Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992; 327:380-4
22. Pumphrey R: Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30:1144-50
23. Tsuda A, Tanaka KA, Huraux C, Szlam F, Sato N, Yamaguchi K, Levy JH: The in vitro reversal of histamine-induced vasodilatation in the human internal mammary artery. Anesth Analg 2001; 93:1453-9
24. Hiruta A, Mitsuhata H, Hiruta M, Horikawa Y, Takeuchi H, Kawakami T, Saitoh J, Seo N: Vasopressin may be useful in the treatment of systemic anaphylaxis in rabbits. Shock 2005; 24:264-9
25. Treschan TA, Peters J: The vasopressin system: Physiology and clinical strategies. ANESTHESIOLOGY 2006; 105:599-612
26. Czaczkes JW: Physiologic studies of antidiuretic hormone by its direct measurement in human plasma. J Clin Invest 1964; 43:1625-40
27. Kam PCA, Williams SR, Yoong FFY: Vasopressin and terlipressin: Pharmacology and its clinical relevance. Anaesthesia 2004; 59:993-1001
28. Smith PL, Kagey-Sobotka A, Bleecker ER, Traystman R, Kaplan AP, Gralnick H, Valentine MD, Permutt S, Lichtenstein LM: Physiologic manifestations of human anaphylaxis. J Clin Invest 1980; 66:1072-80
29. Muelleman RI, Pribble JP, Salomone JA: Blood pressure effects of thyrotropin releasing hormone and epinephrine in anaphylactic shock. Ann Emerg Med 1988; 17:309-13
30. Mink SN, Bands C, Becker A, Elkin J, Sharma S, Unruh H, Kepron W: Effect of bolus epinephrine on systemic hemodynamics in canine anaphylactic shock. Cardiovasc Res 1998; 40:546-56
31. Bautista E, Simons FER, Simons KJ, Becker AB: Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock. Int Arch Allergy Immunol 2002; 128:151-64
32. Mink SN, Simons FER, Simons KJ, Becker AB, Duke K: Constant infusion of epinephrine, but not bolus treatment, improves hemodynamic recovery in anaphylactic shock in dogs. Clin Exp Allergy 2004; 34:1776-83
33. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA: Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997; 25:1279-82
34. Landry D, Oliver J: The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345:588-95
35. Nambi P, Whitman M, Gessner G, Aiyar N, Crooke S: Vasopressin-mediated inhibition of atrial natriuretric factor-stimulated cGMP accumulation in an established smooth muscle cell line. Proc Natl Acad Sci 1986; 83:8492-5
36. Laszlo FA, Laszlo FJ, De Wied D: Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacol Rev 1991; 43:73-108
37. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA: The effects of vasopressin on hemodynamics and renal function in severe septic shock: A case series. Intensive Care Med 2001; 27:1416-21
38. Westphal M, Stubbe H, Sielenkämper AW, Ball C, Van Aken H, Borgulya R, Bone HG: Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep. Crit Care Med 2003; 31:1502-8
39. Ouattara A, Landi M, Le Manach Y, Lecomte P, Leguen M, Boccara G, Coriat P, Riou B: Comparative cardiac effects of terlipressin, vasopressin, and norepinephrine on an isolated perfused rabbit heart. ANESTHESIOLOGY 2005; 102:85-92
40. Patel BM, Chittock DR, Russell JA, Walley KR: Beneficial effects of short-term vasopressin infusion during severe septic shock. ANESTHESIOLOGY 2002; 96:576-82
41. Knotzer H, Pajk W, Maier S, Ladurner R, Kleinsasser A, Wenzel V, Dunser M, Ulmer H, Hasibeder W: Arginine vasopressin reduces intestinal oxygen supply and mucosal tissue oxygen tension. Am J Physiol Heart Circ Physiol 2005; 289:H168-73
42. Dunser MW, Lindner KH, Wenzel V: A century of arginine vasopressin research leading to new therapeutic strategies. ANESTHESIOLOGY 2006; 105:444-5